Document is current

Any future updates will be listed below

189 A clear increase in TILs and modest tumor growth inhibition by pembrolizumab in prostate cancer tumors growing in bone of CD34+ engrafted NOG mice

Crossref DOI link: https://doi.org/10.1136/jitc-2020-SITC2020.0189

Published Online: 2020-12-10

Published Print: 2020-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark